Article Correctness Is Author's Responsibility: CAP Opens Comment Period for MMR/MSI Testing, Advancing Care for Patients with Cancer

Recognizing a need for evidence-based recommendations to guide molecular testing in the management of patients with cancer, the College of American Pathologists (CAP) and three collaborating societies are developing a clinical guideline for testing DNA mismatch repair (MMR) and microsatellite instability (MSI) status in patients with a range of cancer types.